technical paper

ENDO 2021

•

March 21, 2021

•

Live on Underline

Dopamine Agonists: What Are the Real Risks and Side Effects and What Should We Do about Surveillance, and Intervention?

DOI: 10.48448/h3zb-g927

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

technical paper

What Pediatric Endocrinologists Need to Know About Dyslipidemia?

ENDO 2021

21 March 2021

Similar lecture

technical paper

Dysregulation of Lipid Metabolism: Impact on the Beta Cell in Type 2 Diabetes

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial

CONFERENCES

COMPANY

RESOURCES

Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved